SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Teva Pharmaceuticals files Form 8-K

Teva filed a Form 8-K on October 29; the filing’s contents are not provided.

TEVA

Related stories